AstraZeneca PLC (AZN) vs ConocoPhillips (COP)
COP leads on 10 of 16 compared metrics.
A side-by-side comparison of AstraZeneca PLC and ConocoPhillips across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs COP
growth of $100 · last 30yAZN +732.9%COP +658.6%AZN compounded faster
AZN COP
AZN vs COP: by the numbers
- •AZN is the larger company ($277.22B vs $142.52B market cap).
- •COP trades at the lower earnings multiple (19.89 vs 26.92 P/E).
- •AZN converts more revenue to profit (17.19% vs 12.56% net margin).
- •COP grew revenue faster over the past five years (20.71% vs 16.99% CAGR).
- •COP pays the higher dividend yield (2.82% vs 1.79%).
Which is better, AZN or COP?
Metric tally: AZN 6 · COP 10It depends on what you're optimizing for:
ValueCOP(lower P/E)
GrowthCOP(faster 5Y revenue CAGR)
IncomeCOP(higher dividend yield)
QualityAZN(higher ROIC)
Metrics side by side
Valuation
| Metric | AZN | COP |
|---|---|---|
| P/E ratio | 26.92 | 19.89● |
| Forward P/E | 15.33 | 13.01● |
| P/S ratio | 4.62 | 2.46● |
| P/B ratio | 5.90 | 2.22● |
| PEG ratio | 0.14 | — |
| EV / EBITDA | 14.92 | 6.57● |
| FCF yield | 2.89% | 10.73%● |
Profitability
| Metric | AZN | COP |
|---|---|---|
| Gross margin | 81.68%● | 29.18% |
| Operating margin | 23.69%● | 18.28% |
| Net margin | 17.19%● | 12.56% |
| ROE | 21.95%● | 11.34% |
| ROIC | 13.03%● | 6.54% |
Dividends
| Metric | AZN | COP |
|---|---|---|
| Dividend yield | 1.79% | 2.82%● |
| Payout ratio | 48.48% | 51.89% |
Growth (annualized)
| Metric | AZN | COP |
|---|---|---|
| Revenue CAGR (5Y) | 16.99% | 20.71%● |
| EPS CAGR (5Y) | 22.02%● | -0.18% |
| FCF CAGR (5Y) | 15.68% | 97.59%● |
| Total return CAGR (5Y) | 11.03% | 18.54%● |
Frequently asked
- Which is better, AZN or COP?
- It depends on your goal. value: COP (lower P/E); growth: COP (faster 5Y revenue CAGR); income: COP (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, COP leads 10 to 6.
- Is AZN or COP cheaper?
- On trailing earnings, COP is cheaper: AZN trades at a 26.92 P/E and COP at 19.89.
- Which has grown faster, AZN or COP?
- Over the past five years, COP grew revenue faster — AZN at a 16.99% CAGR versus COP at 20.71%.
- Does AZN or COP pay a bigger dividend?
- AZN yields 1.79% and COP yields 2.82% based on trailing dividends and the latest price.
- Is AZN or COP more profitable?
- AZN runs the higher net margin — AZN at 17.19% versus COP at 12.56%.
- Which has been the better investment, AZN or COP?
- Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus COP at 13.65%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioConocoPhillips P/E ratioAstraZeneca dividend yieldConocoPhillips dividend yieldAstraZeneca ROEConocoPhillips ROEAstraZeneca operating marginConocoPhillips operating marginAstraZeneca revenue growthConocoPhillips revenue growthAstraZeneca free cash flowConocoPhillips free cash flow
AstraZeneca & ConocoPhillips appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.